Uterine sarcoma part III—Targeted therapy: The Taiwan Association of Gynecology (TAG) systematic review

Medicine & Life Sciences

• Aurora Kinase A 29%
• Bone Morphogenetic Proteins 24%
• Drug Therapy 11%
• Endometrial Stromal Sarcoma 30%
• Endometrial Stromal Tumors 32%
• Genome 13%
• Gonadal Steroid Hormones 21%
• Gynecology 100%
• Histone Deacetylases 23%
• Intercellular Signaling Peptides and Proteins 16%
• Leiomyosarcoma 23%
• Mutation 11%
• Neoplasms 12%
• Oncogene Proteins 22%
• Phosphatidylinositol 3-Kinase 20%
• Proto-Oncogenes 23%
• Radiotherapy 13%
• Receptor Protein-Tyrosine Kinases 21%
• Sarcoma 93%
• Signal Transduction 30%
• Systematic Reviews 72%
• Therapeutics 16%
• TOR Serine-Threonine Kinases 22%
• Transforming Growth Factors 20%
• Tumor Suppressor Genes 19%
• Wnt Signaling Pathway 22%